Skip to main content

Table 2 Characteristics of individuals with HBV drug resistance mutations

From: Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria

ID

Age (years)

Gender (F/M)

ART regimen

HBV viral load (copies/ml)

CD4 count (cells/ml)

HDV-RNA (+/−)

HDV genotype

HBV-mutations

P-region

OS05

33

M

Combipack

1.34 × 107

700

+

−

L180M, V173L, M204V

OS11

44

M

Combipack

3.36 × 103

800

−

−

L180M, V173L, M204V

OS20

26

F

Combipack

9.87 × 102

740

−

−

L180M, V173L, M204V

OS66

41

F

Combipack

2.26 × 106

150

−

−

L180M, V173L, M204V

OS67

23

F

Combipack

1.46 × 107

625

−

−

L180M, V173L, M204V

OS68

41

M

Combipack

1.10 × 105

640

−

−

L180M, V173L, M204V

OS70

28

F

Combipack

2.11 × 102

800

+

−

L180M, V173L, M204V

OS74

27

M

Combipack

2.62 × 103

385

+

−

V173L, M204V

OFFA159

49

F

Combipack

5.75 × 106

1283

−

−

L180M, M204I

OFFA221

37

F

Naïve

4.36 × 106

243

+

1

L180M, M204V, S202I

  1. Combipack, zidovudine + lamivudine + nevirapine (AZT/3TC/NVP); P-region, Hbv polymerase region (reverse transcriptase)